Evaxion will present new biomarker and immune data obtained from the ongoing phase 2 trial. These will further add to EVX-01’s already strong clinical data package.

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies in 2025 for the treatment of small cell lung cancer Firs ...

Company to present key research advancing digital pathology and host a networking event, H&E by the Sea, on March 25th at 6:00 p.m. ET at Nautilus Pier 4 ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

The Earth Sciences contribute to answers on a wide range of societal and economic questions in areas such as: the natural means of existence (water, raw materials, the energy transition), the ...

Angela Reading’s lawsuit names the Department of Homeland Security and the Transportation Security Administration among the ...

Since the 1940s, the American Heart Association has invested more than $5 billion in research, including more than $90 ...

Dr. Suzi Marasco, assistant professor of Occupational Therapy, will present a poster at the American Occupational Therapy Association national conference on April 4. She will present the poster, ...

Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for ...

The inaugural Women, Gender, and Sexuality Studies symposium, hosted on March 28, will feature original work by individuals ...

Wine in grocery stores gets strong push from supermarkets as new coalition places advocacy in hundreds of supermarkets across ...